Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Furospir Lactab®:Mepha Pharma AG
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
C03EB01 - Furosemide and Potassium-Sparing AgentsATC-DDD Version 2016. Source: WHO
C - Cardiovascular System
C03 - Diuretics

This group comprises diuretics, plain and in combination with potassium or other agents. Vasopressin antagonists are also included in this group. Potassium-sparing agents are classified in C03D and C03E.
Combinations with digitalis glycosides, see C01AA.
Combinations with antihypertensives, see C02L - Antihypertensives and diuretics in combination.
Combinations with beta blocking agents, see C07B - C07D.
Combinations with calcium channel blockers, see C08.
Combinations with agents acting on the renin angiotensin system, see C09B and C09D.

The DDDs for diuretics are based on monotherapy. Most diuretics are used both for the treatment of edema and hypertension in similar doses and the DDDs are therefore based on both indications.
The DDDs for combinations correspond to the DDD for the diuretic component, except for ATC group C03E, see comments under this level.

C03E - Diuretics and Potassium-Sparing Agents in Combination

Fixed DDDs are assigned for combinations in this group.
E.g. 1 tablet regardless of strengths is the DDD assigned for hydrochlorothiazide and amiloride in combinations. See comments to C02L also.

C03EB - High-Ceiling Diuretics and Potassium-Sparing Agents
C03EB01 - Furosemide and Potassium-Sparing Agents
2020 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home